Y-Intercept (HK)’s MediciNova MNOV Stock Holding History

Y-Intercept (HK)’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-36,957	Closed	-$77.6K	–	1460
2024 Q4	$77.6K	Buy	+36,957	New	+$72.1K	0.01%	1111

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Y-Intercept (HK)'s MNOV Position: Q1 2025 in Review

Y-Intercept (HK) sold out of MediciNova (MNOV) in Q1 2025, closing a stake of 36,957 shares — an estimated $77.6K sold.

Y-Intercept (HK) first reported a position in MNOV in Q4 2024 and held it in 1 quarter. The position peaked at $77.6K in Q4 2024. 28 funds tracked by Wall St. Rank hold MNOV as of Q1 2025.

Y-Intercept (HK) reported no remaining MediciNova position as of Q1 2025 after selling out during the quarter.
Y-Intercept (HK) sold 36,957 MediciNova shares in Q1 2025, an estimated $77.6K.
Y-Intercept (HK) first reported a position in MediciNova in Q4 2024 and held it in 1 quarter.
Y-Intercept (HK)'s MediciNova position peaked at $77.6K in Q4 2024.
28 funds tracked by Wall St. Rank held MediciNova as of Q1 2025.

Based on Y-Intercept (HK)'s 13F filing for Q1 2025, filed 6 May 2025.